Daniel S. Strasser

1.2k total citations
41 papers, 722 citations indexed

About

Daniel S. Strasser is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Daniel S. Strasser has authored 41 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Physiology. Recurrent topics in Daniel S. Strasser's work include Asthma and respiratory diseases (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Daniel S. Strasser is often cited by papers focused on Asthma and respiratory diseases (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Daniel S. Strasser collaborates with scholars based in Switzerland, Germany and United States. Daniel S. Strasser's co-authors include Peter Groenen, Michel A. Steiner, Jasper Dingemanse, Anna K. Stalder, Martine Clozel, Beat Ernst, Marc Iglarz, François Jenck, Patrick Hess and Catherine Brisbare‐Roch and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Daniel S. Strasser

40 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel S. Strasser Switzerland 16 233 226 160 85 79 41 722
Wen-Hui Tsai Taiwan 18 287 1.2× 238 1.1× 50 0.3× 50 0.6× 80 1.0× 28 775
Masami Shimizu‐Albergine United States 19 523 2.2× 104 0.5× 100 0.6× 35 0.4× 48 0.6× 25 920
Martine Géhin Switzerland 13 452 1.9× 267 1.2× 166 1.0× 14 0.2× 141 1.8× 28 1.1k
Dan L. Li United States 15 545 2.3× 130 0.6× 103 0.6× 55 0.6× 69 0.9× 26 1.3k
Anita K. Salyers United States 16 202 0.9× 247 1.1× 97 0.6× 39 0.5× 29 0.4× 21 942
Fernand Gobeil Canada 18 342 1.5× 153 0.7× 82 0.5× 41 0.5× 78 1.0× 23 907
Maria S. Gawryl United States 19 467 2.0× 156 0.7× 143 0.9× 18 0.2× 73 0.9× 42 1.2k
Ewa Bałkowiec-Iskra Poland 13 111 0.5× 118 0.5× 104 0.7× 20 0.2× 27 0.3× 31 663
Lucien Gazi Switzerland 15 372 1.6× 216 1.0× 143 0.9× 32 0.4× 62 0.8× 20 712
Ethan J. Stam United States 9 520 2.2× 93 0.4× 391 2.4× 65 0.8× 70 0.9× 10 1.4k

Countries citing papers authored by Daniel S. Strasser

Since Specialization
Citations

This map shows the geographic impact of Daniel S. Strasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Strasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Strasser more than expected).

Fields of papers citing papers by Daniel S. Strasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Strasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Strasser. The network helps show where Daniel S. Strasser may publish in the future.

Co-authorship network of co-authors of Daniel S. Strasser

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Strasser. A scholar is included among the top collaborators of Daniel S. Strasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Strasser. Daniel S. Strasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gnerre, Carmela, et al.. (2024). ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects. Neurochemical Research. 49(8). 2087–2104. 2 indexed citations
3.
4.
Meyer, Emmanuel A., Eric A. Ertel, Daniel S. Strasser, et al.. (2023). Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies. Journal of Medicinal Chemistry. 66(6). 4179–4196. 6 indexed citations
5.
Askanase, Anca, David D’Cruz, Kenneth Kalunian, et al.. (2023). POS1147 EFFICACY OF CENERIMOD IN PATIENTS WITH HIGH IFN-1 GENE EXPRESSION SIGNATURE AND HIGH ANTI-DSDNA ANTIBODY LEVELS: POST-HOC ANALYSIS FROM A PHASE 2 STUDY. Annals of the Rheumatic Diseases. 82. 903–904.
6.
7.
Welford, Richard W.D., Michel A. Steiner, Kostantin Dobrenis, et al.. (2022). Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients. Molecular Genetics and Metabolism Reports. 30. 100843–100843. 17 indexed citations
8.
Huynh, Christine, Daniel S. Strasser, Mohamed Al‐Ibrahim, et al.. (2021). A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. Clinical Pharmacology & Therapeutics. 109(6). 1648–1659. 9 indexed citations
9.
Strasser, Daniel S., Sylvie Froidevaux, Enrico Vezzali, et al.. (2020). Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus. RMD Open. 6(2). e001261–e001261. 19 indexed citations
10.
Kobayashi, Tadahiro, et al.. (2019). Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod. Scientific Reports. 9(1). 658–658. 15 indexed citations
11.
Trensz, F., Markus Rey, Daniel S. Strasser, et al.. (2019). Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension. Journal of Pharmacology and Experimental Therapeutics. 368(3). 462–473. 42 indexed citations
12.
Strasser, Daniel S., et al.. (2018). Eosinophilic oesophagitis: relevance of mast cell infiltration. Histopathology. 73(3). 454–463. 30 indexed citations
13.
Trensz, F., et al.. (2017). Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention. Journal of Pharmacology and Experimental Therapeutics. 361(2). 322–333. 62 indexed citations
14.
Krause, Andreas, Jochen Zisowsky, Daniel S. Strasser, et al.. (2015). Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection. Clinical Pharmacokinetics. 55(7). 813–821. 9 indexed citations
15.
Géhin, Martine, Daniel S. Strasser, Jochen Zisowsky, et al.. (2015). A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects. The Journal of Clinical Pharmacology. 55(7). 787–797. 15 indexed citations
16.
Bauer, Peter, David J. Balding, Hans H. Klünemann, et al.. (2013). Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Human Molecular Genetics. 22(21). 4349–4356. 62 indexed citations
17.
Strasser, Daniel S., et al.. (2012). Sex comparison on long-lasting behavioral and physiological disturbances induced by single shock experience in rats. Physiology & Behavior. 107(2). 243–251. 11 indexed citations
18.
Koliwer‐Brandl, Hendrik, et al.. (2010). Kinetic and thermodynamic properties of MAG antagonists. Carbohydrate Research. 345(10). 1348–1359. 15 indexed citations
19.
Cutting, Brian, Xiaohua Jiang, Hendrik Koliwer‐Brandl, et al.. (2010). A Fragment‐Based In Situ Combinatorial Approach To Identify High‐Affinity Ligands for Unknown Binding Sites. Angewandte Chemie International Edition. 49(33). 5721–5725. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen-Hui Tsai Breakdown of academic impact, for papers by Masami Shimizu‐Albergine Breakdown of academic impact, for papers by Martine Géhin Breakdown of academic impact, for papers by Dan L. Li Breakdown of academic impact, for papers by Anita K. Salyers Breakdown of academic impact, for papers by Fernand Gobeil Breakdown of academic impact, for papers by Maria S. Gawryl Breakdown of academic impact, for papers by Ewa Bałkowiec-Iskra Breakdown of academic impact, for papers by Lucien Gazi Breakdown of academic impact, for papers by Ethan J. Stam
Rankless by CCL
2026